The Effect of Intensity-Modulated Radiotherapy to the Head and Neck Region on the Oral Innate Immune Response and Oral Microbiome: A Prospective Cohort Study of Head and Neck Tumour Patients

Int J Mol Sci. 2022 Aug 24;23(17):9594. doi: 10.3390/ijms23179594.

Abstract

Neutrophils, also known as polymorphonuclear leukocytes (PMNs), form a significant component of the innate host response, and the consequence of the interaction between the oral microbiota and PMNs is a crucial determinant of oral health status. The impact of radiation therapy (RT) for head and neck tumour (HNT) treatment on the oral innate immune system, neutrophils in particular, and the oral microbiome has not been thoroughly investigated. Therefore, the objective of this study was to characterize RT-mediated changes in oral neutrophils (oPMNs) and the oral microbiome in patients undergoing RT to treat HNTs. Oral rinse samples were collected prior to, during and post-RT from HNT patients receiving RT at Dental Oncology at Princess Margaret Cancer Centre. The oPMNs counts and activation states were analysed using flow cytometry, and the oral microbiome was analysed using 16S rRNA gene sequencing. Statistically significant (p < 0.05) drops in oPMN counts and the activation states of the CD11b, CD16, CD18, CD64 and H3Cit markers from pre-RT to post-RT were observed. Moreover, exposure to RT caused a significant reduction in the relative abundance of commensal Gram-negative bacteria and increased the commensal Gram-positive microbes. Ionizing radiation for the treatment of HNTs simultaneously decreased the recruitment of oPMNs into the oral cavity and suppressed their activation state. The oral microbiome composition post-RT was altered significantly due to RT which may favour the colonization of specific microbial communities unfavourable for the long-term development of a balanced oral microbiome.

Keywords: head and neck cancer; head and neck tumour; oral innate immune response; oral microbiome; oral microbiota; oral neutrophils; oral polymorphonuclear leukocytes (oPMNs); radiation therapy; radiotherapy.

MeSH terms

  • Head and Neck Neoplasms* / radiotherapy
  • Humans
  • Immunity, Innate
  • Microbiota*
  • Prospective Studies
  • RNA, Ribosomal, 16S / genetics
  • Radiotherapy
  • Radiotherapy, Intensity-Modulated*

Substances

  • RNA, Ribosomal, 16S

Grants and funding

This research received no external funding.